UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2020.

Commission File Number 001-36866

 

 

SUMMIT THERAPEUTICS PLC

(Translation of registrant’s name into English)

 

 

136a Eastern Avenue

Milton Park, Abingdon

Oxfordshire OX14 4SB

United Kingdom

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 


On February 6, 2020, Summit Therapeutics plc (the “Company”) announced that it achieved the first milestone under its license and collaboration agreement with Eurofarma Laboratórios SA (“Eurofarma”). A $1.0 million milestone payment was triggered by the Company achieving its initial patient enrollment target at its trial sites in Latin America for the Phase 3 clinical trials of ridinilazole for C. difficile infection. The related press release is attached hereto as Exhibit 99.1.

This Report on Form 6-K, including Exhibit 99.1, is hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-232074).


EXHIBIT INDEX

 

Exhibit

Number

  

Description

99.1   

Press Release, dated February 6, 2020


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    SUMMIT THERAPEUTICS PLC

Date: February 6, 2020

    By:  

/s/ Glyn Edwards

     

Glyn Edwards

     

Chief Executive Officer

Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more Summit Therapeutics Charts.
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more Summit Therapeutics Charts.